Pneumonia, Pneumococcal clinical trials
The registry lists 44 studies for Pneumonia, Pneumococcal across more than 10 countries. 2 are recruiting or about to start. 35 of them are mainly about Pneumonia, Pneumococcal (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-09.
Get an email when these change. Save the Pneumonia, Pneumococcal studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Merck Sharp & Dohme LLC (4) · PATH (3) · China National Biotec Group Company Limited (3) · Pfizer (3) · Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd (3) · KEMRI-Wellcome Trust Collaborative Research Program (2) · Sanofi (2) · GPN Vaccines (1)
What is being tested here
Drugs under test in Pneumonia, Pneumococcal studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
Who these studies take
Of the 1 Pneumonia, Pneumococcal studies recruiting now, 1 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (100%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (100%) | 1 (100%) |
| 18 | 1 (100%) | 1 (100%) |
| 30 | 1 (100%) | 1 (100%) |
| 40 | 1 (100%) | 1 (100%) |
| 50 | 1 (100%) | 1 (100%) |
| 65 | 1 (100%) | 1 (100%) |
| 75 | 1 (100%) | 1 (100%) |
| 85 | 1 (100%) | 1 (100%) |
Across all 44 studies, recruiting or not: 41% stop at 75 or younger and 39% at 65; 39% take children; 0% are for women only and 0% for men only; 73% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 44 of 44. search them.
- Artificial Intelligence-driven Virtual Standardized Pediatric Patients TrialRecruitingNCT06699433Not applicable1 country
- Immunogenicity and Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in 2-month-old and 3-month-old Healthy VolunteersNot yet recruitingNCT04357522Phase 31 country
- A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy InfantsCompletedNCT05412030Phase 22 countries
- Pneumococcal Community-Acquired Pneumonia Requiring Hospitalization Among Colombian AdultsCompletedNCT073544251 country
- A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 When Administered Concomitantly With Influenza Vaccine in Adults 50 Years of Age or Older (V116-005, STRIDE-5)CompletedNCT05526716Phase 31 country
- Pneumonia Vaccine Education Intervention StudyCompletedNCT06136832Not applicable1 country
- Study of Gamma PN3 in the ElderlyCompletedNCT06562790Phase 11 country
- Prevention of Missed Opportunities for HIV Diagnosis by Promoting HIV Testing of Patients With Pneumococcal Pneumonia at Nice University Hospital (PneumoVIH)CompletedNCT049092681 country
- A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)CompletedNCT05420961Phase 39 countries
- Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap ClosureCompletedNCT05799976Not applicable1 country
- Evaluation of PCV Schedules in a Naive Population in VietnamCompletedNCT02961231Phase 41 country
- Paediatric Pneumococcal Pneumonia in Malaysia Prior to and During Pneumococcal Conjugate Vaccine (PCV) ImplementationActive, not recruitingNCT049230351 country
- Phase I Clinical Trial of a Candidate PCV13 in Healthy PeopleStatus unknownNCT05602480Phase 11 country
- A Phase 1/Phase 2 Study of Polyvalent Pneumococcal Conjugate Vaccine (V116) in Adults (V116-001)CompletedNCT04168190Phase 1/21 country
- Pneumococcal Vaccination of Multiple Myeloma Patients on Novel AgentsCompletedNCT03619252Phase 41 country
- Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4CompletedNCT04559204Phase 41 country
- Study of 10-valent Pneumococcal Conjugate Vaccine (Pneumosil) Administered in a 2+1 Schedule to Healthy InfantsCompletedNCT03896477Phase 31 country
- Quantitative Polymerase Chain Reaction for Improved Detection of Pneumococci in CAP "CAPTAIN"CompletedNCT033154031 country
- Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected IndividualsWithdrawnNCT00001080Not applicable
- Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4CompletedNCT04790851Phase 41 country
- Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4Status unknownNCT05079152Phase 41 country
- Myocardial Injury and Severe Pneumococcal PneumoniaTerminatedNCT030582111 country
- Lot-to-Lot Consistency of V114 in Healthy Adults (V114-020)CompletedNCT03950856Phase 36 countries
- An Epidemiological Survey to Establish the Spectrum of Circulating Serotypes of S. Pneumoniae, in Patients Older 18 YearsCompletedNCT04464291Not applicable1 country
- Phase 3 Study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in Healthy InfantsCompletedNCT03197376Phase 31 country
- Immunogenicity and Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Healthy Volunteers Aged 2 Years and AboveCompletedNCT04278248Phase 31 country
- Dose-Finding Study of S.Pneumoniae Whole Cell Vaccine Adsorbed to Alum (PATH-wSP) in Healthy Kenyan Adults and ToddlersCompletedNCT02097472Phase 1/21 country
- Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in Healthy Volunteers Aged Above 2 MonthsStatus unknownNCT04108845Phase 11 country
- Pharmacist Impact on Pneumococcal Polysaccharide Vaccination Rates in Patients With Diabetes in a Supermarket Pharmacy ChainCompletedNCT03851978Not applicable1 country
- The Immunogenicity of Simultaneous Administration of Quadrivalent Influenza Vaccine and 23-valent Pneumococcal VaccineCompletedNCT02592486Phase 41 country
- Phase I to Test a New Pneumococcal VaccineCompletedNCT03303976Phase 11 country
- Safety, Tolerability, and Efficacy Study of Prophylactic S. Pneumoniae Vaccine Following Challenge With S. PneumoniaeCompletedNCT02116998Phase 21 country
- Dynamics of the Immune Response in Children to the 23-valent Pneumococcal Capsular Polysaccharide Vaccine (Pneumovax)CompletedNCT03460730Phase 11 country
- PCV10 Reactogenicity and Immunogenicity Study - MalindiStatus unknownNCT01028326Phase 41 country
- Humoral Determinants of Immunity to Pneumococcal InfectionCompletedNCT00304382Phase 41 country
- Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy AdultsCompletedNCT01444352Phase 11 country
- Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in AdultsCompletedNCT00744263Phase 41 country
- Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia PatientsCompletedNCT00323557Phase 21 country
- Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US With Community-Acquired PneumoniaCompletedNCT010863971 country
- Study of an Investigational Pneumococcal Vaccine in Healthy Adult VolunteersCompletedNCT01444001Phase 11 country
- Study of Two Investigational Pneumococcal Vaccines in Healthy AdultsCompletedNCT01444339Phase 11 country
- Targeting of Immune Response After Pneumococcal VaccinationCompletedNCT01402245Phase 41 country
- New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)CompletedNCT00035269Phase 34 countries
- Ceftriaxone Vs Levofloxacin on Cytokine Expression in Pneumococcal PneumoniaTerminatedNCT00429975Phase 41 country